Entera Bio Stock Performance
| ENTX Stock | USD 2.06 0.04 1.90% |
On a scale of 0 to 100, Entera Bio holds a performance score of 8. The firm shows a Beta (market volatility) of -0.13, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Entera Bio are expected to decrease at a much lower rate. During the bear market, Entera Bio is likely to outperform the market. Please check Entera Bio's potential upside, as well as the relationship between the accumulation distribution and price action indicator , to make a quick decision on whether Entera Bio's price patterns will revert.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Entera Bio are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Entera Bio showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 1.45 | Five Day Return (2.78) | Year To Date Return (6.67) | Ten Year Return (66.56) | All Time Return (66.56) |
1 | Acquisition by Yaacov-garbeli Dana of 130000 shares of Entera Bio at 1.99 subject to Rule 16b-3 | 01/10/2025 |
2 | Acquisition by Ellis Sean of 28509 shares of Entera Bio at 2.28 subject to Rule 16b-3 | 01/15/2025 |
3 | Acquisition by Lieberman Gerald M of 28509 shares of Entera Bio at 2.28 subject to Rule 16b-3 | 01/17/2025 |
4 | Entera Bio Ltd. Short Interest Down 23.1 percent in January - MarketBeat | 01/30/2025 |
5 | US Penny Stocks 3 Picks With Market Caps Over 60M | 02/07/2025 |
6 | Entera Bio to Participate in Upcoming Events | 02/24/2025 |
| Begin Period Cash Flow | 12.4 M |
Entera |
Entera Bio Relative Risk vs. Return Landscape
If you would invest 164.00 in Entera Bio on November 28, 2024 and sell it today you would earn a total of 43.00 from holding Entera Bio or generate 26.22% return on investment over 90 days. Entera Bio is currently generating 0.5122% in daily expected returns and assumes 4.9908% risk (volatility on return distribution) over the 90 days horizon. In different words, 44% of stocks are less volatile than Entera, and 90% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Entera Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Entera Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Entera Bio, and traders can use it to determine the average amount a Entera Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1026
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ENTX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.99 actual daily | 44 56% of assets are more volatile |
Expected Return
| 0.51 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 8 92% of assets perform better |
Based on monthly moving average Entera Bio is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Entera Bio by adding it to a well-diversified portfolio.
Entera Bio Fundamentals Growth
Entera Stock prices reflect investors' perceptions of the future prospects and financial health of Entera Bio, and Entera Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Entera Stock performance.
| Return On Equity | -1.45 | ||||
| Return On Asset | -0.71 | ||||
| Operating Margin | (71.93) % | ||||
| Current Valuation | 69.64 M | ||||
| Shares Outstanding | 36.83 M | ||||
| Price To Earning | 2.10 X | ||||
| Price To Book | 11.82 X | ||||
| Price To Sales | 781.29 X | ||||
| Revenue | 14 K | ||||
| Gross Profit | 9 K | ||||
| EBITDA | (8.8 M) | ||||
| Net Income | (8.89 M) | ||||
| Cash And Equivalents | 17.28 M | ||||
| Cash Per Share | 0.60 X | ||||
| Total Debt | 390 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 10.89 X | ||||
| Book Value Per Share | 0.18 X | ||||
| Cash Flow From Operations | (7.31 M) | ||||
| Earnings Per Share | (0.26) X | ||||
| Market Capitalization | 77.35 M | ||||
| Total Asset | 11.77 M | ||||
| Retained Earnings | (104.39 M) | ||||
| Working Capital | 10.17 M | ||||
| Current Asset | 8.46 M | ||||
| Current Liabilities | 7.64 M | ||||
About Entera Bio Performance
Evaluating Entera Bio's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Entera Bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Entera Bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | -1.2 K | -1.2 K | |
| Return On Tangible Assets | (0.68) | (0.71) | |
| Return On Capital Employed | (0.96) | (1.01) | |
| Return On Assets | (0.68) | (0.71) | |
| Return On Equity | (0.98) | (1.03) |
Things to note about Entera Bio performance evaluation
Checking the ongoing alerts about Entera Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Entera Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Entera Bio appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 14 K. Net Loss for the year was (8.89 M) with profit before overhead, payroll, taxes, and interest of 9 K. | |
| Entera Bio currently holds about 17.28 M in cash with (7.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.6. | |
| Entera Bio has a poor financial position based on the latest SEC disclosures | |
| Roughly 19.0% of the company shares are held by company insiders | |
| Latest headline from gurufocus.com: Entera Bio to Participate in Upcoming Events |
- Analyzing Entera Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Entera Bio's stock is overvalued or undervalued compared to its peers.
- Examining Entera Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Entera Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Entera Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Entera Bio's stock. These opinions can provide insight into Entera Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Entera Stock Analysis
When running Entera Bio's price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.